Rescue therapy outcomes with GP IIb/IIIa inhibitors versus fibrinolytics
| Outcome | GP IIb/IIIa Inhibitor % (95% CI) | I2 | Fibrinolytic % (95% CI) | I2 | P Value |
|---|---|---|---|---|---|
| Postoperative clinical stroke | 14.0 (8.0–23.0) | 65 | 27.0 (11.0–51.0) | 53 | .20 |
| Postoperative infarct on imaging | 28.0 (19.0–39.0) | 56 | 39.0 (19.0–63.0) | 0 | .42 |
| Postoperative hemorrhage | 7.0 (4.0–10.0) | 0 | 14.0 (6.0–31.0) | 26 | .12 |
| Perioperative morbidity from stroke/hemorrhage | 11.0 (7.0–16.0) | 10 | 29.0 (13.0–55.0) | 55 | .04 |
| Perioperative mortality from stroke/hemorrhage | 6.0 (4.0–9.0) | 0 | 12.0 (5.0–25.0) | 0 | .16 |
| Long-term good neurologic outcome | 82.0 (78.0–86.0) | 0 | 65.0 (42.0–83.0) | 43 | .07 |
| Long-term morbidity | 16.0 (11.0–21.0) | 13 | 35.0 (17.0–58.0) | 43 | .04 |
| Recanalization rate | 72.0 (64.0–78.0) | 49 | 50.0 (28.0–73.0) | 37 | .08 |